首页> Nucleic acids research> PLZF limits enhancer activity during hematopoietic progenitor aging.

PLZF limits enhancer activity during hematopoietic progenitor aging.

导出 OA

翻译打印收藏纠错

第一作者： Mathilde,Poplineau

第一单位： Epigenetic Factors in Normal and Malignant Hematopoiesis, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.;Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.

作者： Mathilde,Poplineau ^[1] ; Julien,Vernerey ^[2] ; Nadine,Platet ^[2] ; Lia,N'guyen ^[2] ; Léonard,Hérault ^[2] ; Michela,Esposito ^[3] ; Andrew J,Saurin ^[4] ; Christel,Guilouf ^[3] ; Atsushi,Iwama ^[5] ; Estelle,Duprez ^[2]

作者单位： Epigenetic Factors in Normal and Malignant Hematopoiesis, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.;Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. ^[1] Epigenetic Factors in Normal and Malignant Hematopoiesis, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France. ^[2] Gustave Roussy, Université Paris-Saclay, Inserm U1170, CNRS Villejuif, France. ^[3] Aix Marseille Université, CNRS, IBDM, Marseille, France. ^[4] Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.;Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan. ^[5]